We identified 10 tumors out of 198 (5%) carrying POLE mutation in the exonuclease domain in the selected cohort whereas only one tumor out of 222 (0.5%) was mutated in the nonselected cohort (Chi‐square test, P = 0.0032). The gene discussed is POLE; the disease is neoplasm.